Treatment Strategies for Metastatic Soft Tissue Sarcomas

by Lisette M. Wiltink, Rick L. M. Haas, Hans Gelderblom, Michiel A. J. van de Sande
Published 2021-04-01

Limb Amputation after Multiple Treatments of Tenosynovial Giant Cell Tumour: Series of 4 Dutch Cases

by Monique J. L. Mastboom, Floortje G. M. Verspoor, Hans Gelderblom, Michiel A. J. van de Sande
Published 2017-01-01

Regression of fibrous dysplasia in response to denosumab therapy: A report of two cases

by Maartje E. Meier, Wouter van der Bruggen, Michiel A.J. van de Sande, Natasha M. Appelman-Dijkstra
Published 2021-06-01

Use of the Composite Pedicled Pectoralis Minor Flap after Resection of Soft Tissue Sarcoma in Reconstruction of the Glenohumeral Joint

by Michiel A. J. van de Sande, Tom Cosker, Stephen M. McDonnell, C. L. M. H. Gibbons, Henk Giele
Published 2014-01-01

Time Trends and Prognostic Factors for Overall Survival in Myxoid Liposarcomas: A Population-Based Study

by Jules Lansu, Winan J. Van Houdt, Michael Schaapveld, Iris Walraven, Michiel A. J. Van de Sande, Vincent K. Y. Ho, Rick L. Haas
Published 2020-01-01

Individualized approach to the surgical management of fibrous dysplasia of the proximal femur

by Bas C. J. Majoor, Andreas Leithner, Michiel A. J. van de Sande, Natasha M. Appelman-Dijkstra, Neveen A. T. Hamdy, P. D. Sander Dijkstra
Published 2018-05-01

Incidence and demographics of giant cell tumor of bone in The Netherlands: First nationwide Pathology Registry Study

by Arie J Verschoor, Judith V M G Bovée, Monique J L Mastboom, P D Sander Dijkstra, Michiel A J Van De Sande, Hans Gelderblom
Published 2018-09-01

Determinants of impaired quality of life in patients with fibrous dysplasia

by Bas C. J. Majoor, Cornelie D. Andela, Jens Bruggemann, Michiel A. J. van de Sande, Ad A. Kaptein, Neveen A. T. Hamdy, P. D. Sander Dijkstra, Natasha M. Appelman-Dijkstra
Published 2017-04-01

Cross-Cultural Adaptation, Translation, and Validation of the Toronto Extremity Salvage Score for Extremity Bone and Soft Tissue Tumor Patients in Netherlands

by Julie J. Willeumier, C. W. P. G. van der Wal, Robert J. P. van der Wal, P. D. S. Dijkstra, Thea P. M. Vliet Vlieland, Michiel A. J. van de Sande
Published 2017-01-01

Survival Analysis of 3 Different Age Groups and Prognostic Factors among 402 Patients with Skeletal High-Grade Osteosarcoma. Real World Data from a Single Tertiary Sarcoma Center

by Richard E. Evenhuis, Ibtissam Acem, Anja J. Rueten-Budde, Diederik S. A. Karis, Marta Fiocco, Desiree M. J. Dorleijn, Frank M. Speetjens, Jakob Anninga, Hans Gelderblom, Michiel A. J. van de Sande
Published 2021-01-01

The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study

by Nicholas M. Bernthal, Geert Spierenburg, John H. Healey, Emanuela Palmerini, Sebastian Bauer, TOPP Study Group, Hans Gelderblom, Eric L. Staals, Julio Lopez-Bastida, Eva-Maria Fronk, Xin Ye, Petra Laeis, Michiel A. J. van de Sande
Published 2021-04-01

Candidate Biomarkers for Specific Intraoperative Near-Infrared Imaging of Soft Tissue Sarcomas: A Systematic Review

by Zeger Rijs, A. Naweed Shifai, Sarah E. Bosma, Peter J. K. Kuppen, Alexander L. Vahrmeijer, Stijn Keereweer, Judith V. M. G. Bovée, Michiel A. J. van de Sande, Cornelis F. M. Sier, Pieter B. A. A. van Driel
Published 2021-02-01

Carriers of loss-of-function mutations in EXT display impaired pancreatic beta-cell reserve due to smaller pancreas volume.

by Sophie J Bernelot Moens, Hans L Mooij, H Carlijne Hassing, Janine K Kruit, Julia J Witjes, Michiel A J van de Sande, Aart J Nederveen, Ding Xu, Geesje M Dallinga-Thie, Jeffrey D Esko, Erik S G Stroes, Max Nieuwdorp
Published 2014-01-01

Higher incidence rates than previously known in tenosynovial giant cell tumors: A nationwide study in The Netherlands

by Monique J L Mastboom, Floortje G M Verspoor, Arjan J Verschoor, Daniël Uittenbogaard, Banne Nemeth, Walter J B Mastboom, Judith V M G Bovée, P D Sander Dijkstra, H W Bart Schreuder, Hans Gelderblom, Michiel A J Van de Sande, TGCT study group
Published 2017-11-01

The Perceived Impact of Length of the Diagnostic Pathway Is Associated with Health-Related Quality of Life of Sarcoma Survivors: Results from the Dutch Nationwide SURVSARC Study

by Vicky L. M. N. Soomers, Ingrid M. E. Desar, Lonneke V. van de Poll-Franse, Michiel A. J. van de Sande, Jacco J. de Haan, Cornelis Verhoef, Ingeborg J. H. Vriens, Winan J. van Houdt, Johannes J. Bonenkamp, Winette T. A. van der Graaf, Olga Husson
Published 2020-07-01

Unraveling the Heterogeneity of Sarcoma Survivors’ Health-Related Quality of Life Regarding Primary Sarcoma Location: Results from the SURVSARC Study

by Ilse van Eck, Dide den Hollander, Ingrid M.E. Desar, Vicky L.M.N. Soomers, Michiel A.J. van de Sande, Jacco J. de Haan, Cornelis Verhoef, Ingeborg J.H. Vriens, Johannes J. Bonenkamp, Winette T.A. van der Graaf, Winan J. van Houdt, Olga Husson
Published 2020-10-01

Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans[S]

by Hans L. Mooij, Sophie J. Bernelot Moens, PhilipL.S.M. Gordts, KristinI. Stanford, ErinM. Foley, MarjoleinA.W. van den Boogert, JuliaJ. Witjes, H.Carlijne Hassing, MichaelW. Tanck, MichielA.J. van de Sande, J.Han Levels, JohnJ.P. Kastelein, ErikS.G. Stroes, GeesjeM. Dallinga-Thie, JeffD. Esko, Max Nieuwdorp
Published 2015-03-01

Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors

by Dario Callegaro, Rosalba Miceli, Sylvie Bonvalot, Peter C. Ferguson, Dirk C. Strauss, Veroniek V.M. van Praag, Antonin Levy, Anthony M. Griffin, Andrew J. Hayes, Silvia Stacchiotti, Cecile Le Pèchoux, Myles J. Smith, Marco Fiore, Angelo Paolo Dei Tos, Henry G. Smith, Charles Catton, Joanna Szkandera, Andreas Leithner, Michiel A.J. van de Sande, Paolo G. Casali, Jay S. Wunder, Alessandro Gronchi
Published 2019-12-01